![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ![]() Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. | ![]() KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. | |
Founding Date | Founding Date 2006 | Founding Date 1994 | Founding Date 2006 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Newark, US HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US |
Employees | Employees 39 | Employees 781% decrease | Employees 333% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $106.5m (FY, 2025) |
Net income | Net income (£2.6m) (FY, 2018) | Net income N/A | Net income $83.2m (FY, 2025) |
Funding | |||
Latest funding round | Latest funding round $ 9.4m (over 12 years ago) | Latest funding round $ 10m (almost 16 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 57.3m | Total funding raised $ 37m | Total funding raised N/A |

Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View company
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View company